Vaccination of poultry against highly pathogenic avian influenza: Part 2. Surveillance and mitigation measures

EFSA Panel on Animal Health and Animal Welfare (AHAW)

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Selecting appropriate diagnostic methods that take account of the type of vaccine used is important when implementing a vaccination programme against highly pathogenic avian influenza (HPAI). If vaccination is effective, a decreased viral load is expected in the samples used for diagnosis, making molecular methods with high sensitivity the best choice. Although serological methods can be reasonably sensitive, they may produce results that are difficult to interpret. In addition to routine molecular monitoring, it is recommended to conduct viral isolation, genetic sequencing and phenotypic characterisation of any HPAI virus detected in vaccinated flocks to detect escape mutants early. Following emergency vaccination, various surveillance options based on virological testing of dead birds ('bucket sampling') at defined intervals were assessed to be effective for early detection of HPAIV and prove disease freedom in vaccinated populations. For ducks, virological or serological testing of live birds was assessed as an effective strategy. This surveillance could be also applied in the peri-vaccination zone on vaccinated establishments, while maintaining passive surveillance in unvaccinated chicken layers and turkeys, and weekly bucket sampling in unvaccinated ducks. To demonstrate disease freedom with > 99% confidence and to detect HPAI virus sufficiently early following preventive vaccination, monthly virological testing of all dead birds up to 15 per flock, coupled with passive surveillance in both vaccinated and unvaccinated flocks, is recommended. Reducing the sampling intervals increases the sensitivity of early detection up to 100%. To enable the safe movement of vaccinated poultry during emergency vaccination, laboratory examinations in the 72 h prior to the movement can be considered as a risk mitigation measure, in addition to clinical inspection; sampling results from existing surveillance activities carried out in these 72 h could be used. In this Opinion, several schemes are recommended to enable the safe movement of vaccinated poultry following preventive vaccination.

Original languageEnglish
Article numbere8755
Number of pages70
JournalEFSA Journal
Volume22
Issue number4
DOIs
Publication statusPublished - Apr 2024

Bibliographical note

Publisher Copyright:
© 2024 European Food Safety Authority, European Union Reference Laboratory for Avian Influenza. EFSA Journal published by Wiley-VCH GmbH on behalf of European Food Safety Authority.

Funding

EFSA and EURL wish to thank the following Member States and their representatives who provided data on HPAI vaccines, poultry population and HPAI outbreaks: Karen Bucher, Bianca Quercetti and Andrea Jimenez Pellicer for France; Andrea Maroni Ponti and Luigi Ruocco for Italy; Borb\u00E1la Bende and G\u00E1bor Wyszoczky for Hungary; Annemarie Bouma and Wim Pelgrim for The Netherlands. As well as thanking the following experts from National Reference Laboratories (NRL) on avian influenza and pharmaceutical industries for providing data on serological studies: Belgium \u2013 Fiona Ingrao, Julie Valentin, and B\u00E9n\u00E9dicte Lambrecht, Huvepharma and CEVA; France \u2013 Beatrice Grasland; the Netherlands \u2013 Kim Bouwman and Nancy Beerens, MSD Animal Health, Huvepharma, Boehringer Ingelheim Animal Health and Ceva; Italy \u2013 Francesco Bonfante, Lucrezia Vianello, Sami Ramzi and Calogero Terregino. EFSA and EURL wish to acknowledge Beatrice Grasland as hearing expert from ANSES, Eleonora Bastino as hearing expert from the European Medicines Agency (EMA), Alexandre Fediaevsky as hearing expert from the World Organisation for Animal Health (WOAH), Francesca Scolamacchia as Individual Scientific Advisor (contract EOI/EFSA/SCIENCE/2020/01), the WBVR for the work done on modelling the surveillance strategies under contract OC/EFSA/ALPHA/2020/01, and the project KB\u201037\u2010003\u2010047\u2010WBVR, and Roxane Delacourt and Gina Cioacata from EFSA for the support provided to this scientific output. EFSA and EURL wish to thank the following Member States and their representatives who provided data on HPAI vaccines, poultry population and HPAI outbreaks: Karen Bucher, Bianca Quercetti and Andrea Jimenez Pellicer for France; Andrea Maroni Ponti and Luigi Ruocco for Italy; Borb\u00E1la Bende and G\u00E1bor Wyszoczky for Hungary; Annemarie Bouma and Wim Pelgrim for The Netherlands. As well as thanking the following experts from National Reference Laboratories (NRL) on avian influenza and pharmaceutical industries for providing data on serological studies: Belgium \u2013 Fiona Ingrao, Julie Valentin, and B\u00E9n\u00E9dicte Lambrecht, Huvepharma and CEVA; France \u2013 Beatrice Grasland; the Netherlands \u2013 Kim Bouwman and Nancy Beerens, MSD Animal Health, Huvepharma, Boehringer Ingelheim Animal Health and Ceva; Italy \u2013 Francesco Bonfante, Lucrezia Vianello, Sami Ramzi and Calogero Terregino. EFSA and EURL wish to acknowledge Beatrice Grasland as hearing expert from ANSES, Eleonora Bastino as hearing expert from the European Medicines Agency (EMA), Alexandre Fediaevsky as hearing expert from the World Organisation for Animal Health (WOAH), Francesca Scolamacchia as Individual Scientific Advisor (contract EOI/EFSA/SCIENCE/2020/01), the WBVR for the work done on modelling the surveillance strategies under contract OC/EFSA/ALPHA/2020/01, and the project KB-37-003-047-WBVR, and Roxane Delacourt and Gina Cioacata from EFSA for the support provided to this scientific output.

FundersFunder number
World Organisation for Animal Health (WOAH)EOI/EFSA/SCIENCE/2020/01
WBVR for the work done on modelling the surveillance strategiesOC/EFSA/ALPHA/2020/01
EFSAKB-37-003-047-WBVR

    Keywords

    • avian influenza transmission
    • highly pathogenic avian influenza (HPAI)
    • poultry
    • surveillance
    • surveillance strategies

    Fingerprint

    Dive into the research topics of 'Vaccination of poultry against highly pathogenic avian influenza: Part 2. Surveillance and mitigation measures'. Together they form a unique fingerprint.

    Cite this